Latest BioCrine News & Updates
See the latest news and media coverage for BioCrine. We track all announcements, press releases, and industry mentions in real time, all in one place.
Biotechnology company developing diabetes treatments
biocrine.com- Founded year
- 2008
- Company type
- Private company
- Number of employees
- 2–10
Last updated
Latest news about BioCrine
In short: BioCrine highlighted research on diet-induced pancreatic damage and advanced technology for islet transplantation and diabetes screening.
Company announcements
-
BioCrine calls annual general meeting on 26 June 2025
The meeting is held at 11:00 at Rolf Luft Research Centre in Solna. Record date is 2025-06-17 and last registration date 2025-06-23.
-
BioCrine calls for annual general meeting on June 17, 2024
The place is Redeye AB in Stockholm at 3:00 p.m. Record date 2024-06-07. Last registration 2024-06-12.
-
Professor Per-Olof Berggren awarded ERC Proof of Concept grant
Funding advances technology transplanting islets into eye's anterior chamber for diabetes drug screening.
-
BioCrine calls for annual general meeting on June 16, 2023
The place is Mäster Samuelsgatan 42, Stockholm at 13:00. Record date 2023-06-08. Last registration 2023-06-13.
Media coverage
Track BioCrine and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
BioCrine competitors & trending companies
Browse news for competitors to BioCrine and other trending companies.
Abarceo Pharma
Diamyd Medical
NextCell Pharma
Pila Pharma
Fractyl Health
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One